22952-43-8

Usage

Uses

Used in Pharmaceutical Industry:
3-Chloro-4-methoxybenzenesulfonyl chloride is used as a reagent for the synthesis of various organic compounds, specifically in the development of drugs and pharmaceutical intermediates. Its unique structure and reactivity make it a valuable component in the creation of new medicinal agents.
Used in Agrochemical Production:
3-Chloro-4-methoxybenzenesulfonyl chloride also serves as a building block in the production of agrochemicals, where its chemical properties contribute to the formulation of effective products for agricultural applications.
Used in Dye Manufacturing:
3-Chloro-4-methoxybenzenesulfonyl chloride is utilized in the manufacturing of dyes, where its chemical structure imparts specific color characteristics and properties to the final products.
Used in Specialty Chemicals Production:
3-Chloro-4-methoxybenzenesulfonyl chloride is also employed in the production of specialty chemicals, where its unique attributes are harnessed to create high-value chemical products for specific industrial applications.

InChI:InChI=1/C7H6Cl2O3S/c1-12-7-3-2-5(4-6(7)8)13(9,10)11/h2-4H,1H3

Upstream product

• 766-51-8 2-Chloroanisole 

Downstream Products

• 792168-92-4 3-chloro-4-methoxy-benzenesulfinic acid 
• 30222-65-2 C₁₀H₁₃ClN₂O₅S 
• 530115-80-1 C₁₅H₁₉ClFNO₅S 
• 1015170-13-4 3-chloro-N-[ethylamino-(4-ethyl-4,5-dihydro-pyrazol-1-yl)-methylene]-4-methoxybenzenesulfonamide 

Relevant academic research and scientific papers

SULFONAMIDE COMPOUNDS AND USES AS TNAP INHIBITORS

Described herein are compounds that modulate the activity of TNAP. In some embodiments, the compounds described herein inhibit TNAP. In certain embodiments, the compounds described herein are useful in the treatment of conditions associated with hyper- mineralization.

ARYLSULFONYL PYRAZOLINE CARBOXAMIDINE DERIVATIVES AS 5-HT6 ANTAGONISTS

This invention concerns arylsulfonyl pyrazoline carboxamidine derivatives as antagonists of 5- HT6 receptors, to methods for the preparation of these compounds and to novel intermediates useful for their synthesis. The invention also relates to the uses of such compounds and compositions, particularly their use in administering them to patients to achieve a therapeutic effect in Parkinson's disease, Huntington's chorea, schizophrenia, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's disease, age related cognitive decline, mild cognitive impairment, sleep disorders, eating disorders, anorexia, bulimia, binge eating disorders, panic attacks, akathisia, attention deficit hyperactivity disorder, attention deficit disorder, withdrawal from abuse of cocaine, ethanol, nicotine or benzodiazepines, pain, disorders associated with spinal trauma or head injury, hydrocephalus, functional bowel disorder, Irritable Bowel Syndrome, obesity and type-2 diabetes. The compounds have the general formula (1) wherein the symbols have the meanings given in the description.

PPAR ACTIVE COMPOUNDS

Compounds are described that are active on PPARs, including pan-active compounds. Also described are methods for developing or identifying compounds having a desired selectivity profile.

SUBSTITUTED DIHYDROPHENANTHRIDINESUL FONAMIDES

This invention provides a compound of formulae (I) or (II) having the structure or a pharmaceutically acceptable salt thereof which are useful for the treatment of the inflammatory component of diseases and are particularly useful in treating atherosclerosis, myocardial infarction, congestive heart failure, inflammatory bowel disease, arthritis, type II diabetes, and autoimmune diseases such as multiple sclerosis and rheumatiod arthritis.

CANNABINOID RECEPTOR LIGANDS

There are disclosed compounds of the formula I: or a pharmaceutically acceptable salt of the compound, which exhibit anti-inflammatory and immunomodulatory activity. Also disclosed are pharmaceutical compositions containing said compounds.